Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
nalbuphine delta-type opioid receptor small molecule NA drugbank , DGIDB Pain[MeSHID:D010146]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Pruritus[MeSHID:D011537]
Prurigo[MeSHID:D011536]
0.98 approved antagonist
nalbuphine delta-type opioid receptor small molecule NA drugbank , DGIDB Pain[MeSHID:D010146]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Pruritus[MeSHID:D011537]
Prurigo[MeSHID:D011536]
0.98 approved antagonist,agonist
nalbuphine kappa-type opioid receptor small molecule NA drugbank , DGIDB Pain[MeSHID:D010146]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Pruritus[MeSHID:D011537]
Prurigo[MeSHID:D011536]
1.79 approved agonist
nalbuphine opioid receptor kappa NA Successful target TTD , DGIDB Pain[MeSHID:D010146]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Pruritus[MeSHID:D011537]
Prurigo[MeSHID:D011536]
1.79 approved agonist
nalbuphine opioid receptor kappa NA Successful target TTD , DGIDB Pain[MeSHID:D010146]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Pruritus[MeSHID:D011537]
Prurigo[MeSHID:D011536]
1.79 approved unknown
nalbuphine mu-type opioid receptor small molecule NA drugbank , DGIDB Pain[MeSHID:D010146]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Pruritus[MeSHID:D011537]
Prurigo[MeSHID:D011536]
1.11 approved antagonist,agonist
nalbuphine mu-type opioid receptor small molecule NA drugbank , DGIDB Pain[MeSHID:D010146]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Pruritus[MeSHID:D011537]
Prurigo[MeSHID:D011536]
1.11 approved antagonist
click here to return to the previous page